Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10008216HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10026116HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10048269HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10048270HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10052479HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10052709HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30084289HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30088779HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30018326HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30026961HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB12278
Drug NamePropiverine
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs16406943
CitationsMaruyama S, Oki T, Otsuka A, Shinbo H, Ozono S, Kageyama S, Mikami Y, Araki I, Takeda M, Masuyama K, Yamada S: Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder. J Urol. 2006 Jan;175(1):365-9.
GroupsApproved; Investigational
Direct ClassificationDiphenylmethanes
SMILESCCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL1078261